Inventia Hlthcare Company Profile
✉ Email this page to a colleague
What is the competitive landscape for INVENTIA HLTHCARE
INVENTIA HLTHCARE has three approved drugs.
Drugs and US Patents for Inventia Hlthcare
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inventia Hlthcare | BUSPIRONE HYDROCHLORIDE | buspirone hydrochloride | TABLET;ORAL | 209696-005 | May 3, 2018 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Inventia Hlthcare | TOLTERODINE TARTRATE | tolterodine tartrate | CAPSULE, EXTENDED RELEASE;ORAL | 204562-002 | Aug 19, 2019 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Inventia Hlthcare | BUSPIRONE HYDROCHLORIDE | buspirone hydrochloride | TABLET;ORAL | 209696-002 | May 3, 2018 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Inventia Hlthcare | FLUOXETINE HYDROCHLORIDE | fluoxetine hydrochloride | TABLET;ORAL | 209695-001 | Nov 20, 2017 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

